Noninvasive markers of inflammatory bowel disease activity

Aim of investigation. To study noninvasive activity markers of inflammatory bowel diseases (IBD) and to estimate correlation between various diagnostic methods for an assessment of clinical and endoscopical activity of ulcerative colitis (UC) and Crohn's disease (CD). Material and methods. Orig...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Nikitin, L. V. Vasilyeva, Anatoly A. Matiukhin
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/101
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860290604761088
author A. V. Nikitin
L. V. Vasilyeva
Anatoly A. Matiukhin
author_facet A. V. Nikitin
L. V. Vasilyeva
Anatoly A. Matiukhin
author_sort A. V. Nikitin
collection DOAJ
description Aim of investigation. To study noninvasive activity markers of inflammatory bowel diseases (IBD) and to estimate correlation between various diagnostic methods for an assessment of clinical and endoscopical activity of ulcerative colitis (UC) and Crohn's disease (CD). Material and methods. Original study included 67 patients with UC and CD in whom clinical and endoscopic activity of the disease with assessed by histological investigation of biopsy specimens. Blood serum cytokines: IL-4, IL-8, tumor necrosis factor α (TNF-α) and fecal calcium binding protein (calprotectin) were assessed. Results. Fecal calprotectin and TNF-α levels were much higher in patients with high disease activity and extent of inflammatory process. Spearman correlation coefficient between endoscopic features and fecal calprotectin (0,82) was higher in the UC patients, than between endoscopic parameters and TNF-α (0,78) in CD patients. Conclusions. Noninvasive inflammatory activity markers should be taken into account and decision-making on diagnostic and treatment strategy, as well as to decrease expensive and invasive diagnostic procedures.
format Article
id doaj-art-77e995462c014dccbee0b494a43cce8e
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-77e995462c014dccbee0b494a43cce8e2025-02-10T16:14:29ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-0126610611110.22416/1382-4376-2016-6-106-111101Noninvasive markers of inflammatory bowel disease activityA. V. Nikitin0L. V. Vasilyeva1Anatoly A. Matiukhin2State educational state-funded institution of higher professional education «Burdenko Voronezh state medical academy»; Voronezh regional hospital No. 1State educational state-funded institution of higher professional education «Burdenko Voronezh state medical academy»; Voronezh regional hospital No. 1State educational state-funded institution of higher professional education «Burdenko Voronezh state medical academy»; Voronezh regional hospital No. 1Aim of investigation. To study noninvasive activity markers of inflammatory bowel diseases (IBD) and to estimate correlation between various diagnostic methods for an assessment of clinical and endoscopical activity of ulcerative colitis (UC) and Crohn's disease (CD). Material and methods. Original study included 67 patients with UC and CD in whom clinical and endoscopic activity of the disease with assessed by histological investigation of biopsy specimens. Blood serum cytokines: IL-4, IL-8, tumor necrosis factor α (TNF-α) and fecal calcium binding protein (calprotectin) were assessed. Results. Fecal calprotectin and TNF-α levels were much higher in patients with high disease activity and extent of inflammatory process. Spearman correlation coefficient between endoscopic features and fecal calprotectin (0,82) was higher in the UC patients, than between endoscopic parameters and TNF-α (0,78) in CD patients. Conclusions. Noninvasive inflammatory activity markers should be taken into account and decision-making on diagnostic and treatment strategy, as well as to decrease expensive and invasive diagnostic procedures.https://www.gastro-j.ru/jour/article/view/101воспалительные заболевания кишечникаязвенный колитболезнь кронаинтерлейкиныкальпротектин
spellingShingle A. V. Nikitin
L. V. Vasilyeva
Anatoly A. Matiukhin
Noninvasive markers of inflammatory bowel disease activity
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
воспалительные заболевания кишечника
язвенный колит
болезнь крона
интерлейкины
кальпротектин
title Noninvasive markers of inflammatory bowel disease activity
title_full Noninvasive markers of inflammatory bowel disease activity
title_fullStr Noninvasive markers of inflammatory bowel disease activity
title_full_unstemmed Noninvasive markers of inflammatory bowel disease activity
title_short Noninvasive markers of inflammatory bowel disease activity
title_sort noninvasive markers of inflammatory bowel disease activity
topic воспалительные заболевания кишечника
язвенный колит
болезнь крона
интерлейкины
кальпротектин
url https://www.gastro-j.ru/jour/article/view/101
work_keys_str_mv AT avnikitin noninvasivemarkersofinflammatoryboweldiseaseactivity
AT lvvasilyeva noninvasivemarkersofinflammatoryboweldiseaseactivity
AT anatolyamatiukhin noninvasivemarkersofinflammatoryboweldiseaseactivity